Study | Technology | Sample type | Candidate/identified lncRNAs | Upregulated lncRNAs (n) | Downregulated lncRNAs (n) | |
T cells | ||||||
Tsitsiou et al 32 | Microarray | Human CD4+ T cells from circulating blood Severe asthma (n=12), healthy subjects (n=8) | AC090517.2 | Severe asthma versus healthy: 0 | Severe asthma versus healthy: 6 | |
Human CD8+ T cells from circulating blood Severe asthma (n=12), healthy subjects (n=8) | MEG3, SNHG3, FBLL1, GHRLOS | Severe asthma versus healthy: 141 | Severe asthma versus healthy: 26 | |||
Qi et al 33 | Microarray | Human CD4+ T cells from circulating blood Asthma (n=5), healthy subjects (n=5) | lnc-NOS2-1, lnc-FAM222B-1
| Asthma versus control: 863 | Asthma versus control: 1862 | |
Qiu et al 34 | Microarray | Human CD4+ T cells from circulating blood Severe asthma (n=52), healthy subjects (n=45) | MALAT1, MEG3, GAS5, NEAT1, DANCR, HULC, FTLP3, KCNA3, CACS7 | Severe asthma versus healthy: 112 | Severe asthma versus healthy: 113 | |
Blood | ||||||
Chen et al 37 | Next-generation sequencing | Human whole blood severe asthma (n=3), mild asthma (n=3) healthy subjects (n=3) | RP5-857K21.7, RP11-58A11.2, lnc-TRAP1-1 | Mild versus normal: 20 Severe versus normal: 504 Severe versus mild: 50 | Mild versus normal: 76 Severe versus normal: 104 Severe versus mild: 93 | |
Zhu et al 39 | Next-generation sequencing | Human whole blood Eosinophilic asthma (n=9 of which n=6 had high IgE and n:3 had low IgE) and control subjects (n=3) | HNRNPU-AS1, RP11-4O1.2, RP5-998N21.4, XLOC_000953, OIP5-AS1, SCARNA10, XLOC_011115 | Asthma versus control: 27 | Asthma versus control: 14 | |
Zhu et al 38 | Next-generation sequencing | Human whole blood Neutrophilic asthma (n=6), eosinophilic asthma (n=12) and control subjects (n=6) | LNC_000127 | Asthma versus control: 117 | Asthma versus control: 178 | |
Airways | ||||||
Liu et al 40 | Microarray | Human airway epithelial brushings Asthma (n=62) and healthy controls (n=43) | AC124067.4, ZNF667AS1, AC005906.2, AL357568.2, AC130650.2, STX18AS1, LINC02363, LINC02145 | Asthma versus control: 48 | Asthma versus control: 111 | |
Austin et al 41 | Microarray | Human primary ASMCs Non-severe asthma (n=9), severe asthma (n=9) and healthy controls (n=9) | PVT1, LINC00472, RP5-1158E12.3, FKBP1A-SDCBP2 | Non-severe versus control: 15 Severe versus control: 13 | Non-severe versus control: 6 Severe versus control: 6 |
A selection of lncRNAs of interest based on the focus of the article or literature is mentioned in the table.
ASMC, airway smooth muscle cell; lncRNA, long non-coding RNA.